Charlotte's Web Joins Alliance Supporting Responsible CBD Regulation
According to a September 19th report by PR Newswire, Charlotte's Web, a leading company in the CBD industry, has become a founding member of ONE HEMP. ONE HEMP is an alliance comprised of top stakeholders in the CBD industry, aiming to support Congress and the U.S. Food and Drug Administration (FDA) in achieving rational regulation of dietary supplements through scientific and data-supported approaches.
As leaders in the CBD market, which is based on cannabis, we prioritize science, safety, and responsible business practices. We stand united with ONE HEMP in bringing clarity and stability to the market. The CBD industry and Congress should have taken action long ago," said Jared Stanley, co-founder and COO of Charlotte's Web. "It has been a decade since cannabis-based CBD became a healthy choice for over 45 million daily CBD consumers in the US. Over these ten years, rigorous scientific research, innovation, safety and toxicology studies, current good manufacturing practices, label standards, and valuable consumer feedback have all demonstrated the self-regulation implemented by responsible CBD suppliers to build a new industry.
Charlotte's Web Holdings, Inc. is a B-grade certified company headquartered in Louisville, Colorado. It is a market leader in innovative cannabis extract health products, with brands such as Charlotte's Web™, ReCreate™, CBD Medic™, and CBD Clinic™. Charlotte's Web offers full-spectrum and broad-spectrum options for their plant-based CBD extract, including ReCreate™ by Charlotte's Web and NSF for Sport certified broad-spectrum CBD®.
ONE HEMP's founding mission is to urge Congress and the FDA to establish regulatory standards that classify CBD products as dietary supplements and serve as a leading scientific resource for policymakers to ensure consumer safety and consistency. ONE HEMP is an industry working group composed of leading voices and CBD market leaders. The group has recruited some of the world's foremost cannabinoid researchers and toxicologists to ensure their approaches are firmly rooted in reliable scientific research and a deep understanding of CBD's safety profile. ONE HEMP aims to set industry benchmarks and foster trust and innovation in the CBD field.
Disclaimer:
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.
